GLPG0187 is a broad spectrum integrin receptor antagonist with antitumor activity; inhibits α v β 1 -integrin with an IC 50 of 1.3 nM. GLPG0187 inhibits migrasome biogenesis without cytotoxicity.
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Cytoskeleton | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Integrin
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.